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N-3 PUFAs induce inﬂammatory tolerance by formation of KEAP1-containing
SQSTM1/p62-bodies and activation of NFE2L2


Jennifer Mildenbergera,b, Ida Johanssona, Ismail Sergind, Eli Kjøblib, Jan Kristian Damasa,c, Babak Razanid,e,
Trude Helen Floa, and Geir Bjørkøya,b
a
Centre of Molecular Inﬂammation Research and Department of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences,
Norwegian University of Science and Technology, Trondheim, Norway; bDepartment of Biomedical Laboratory Science, Faculty of Natural Sciences,
Norwegian University of Science and Technology, Trondheim, Norway; cDepartment of Infectious Diseases, St Olav University Hospital, Trondheim,
Norway; dDepartment of Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA; eDepartment of Pathology
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ABSTRACT

ARTICLE HISTORY

Inﬂammation is crucial in the defense against infections but must be tightly controlled to limit detrimental
hyperactivation. Our diet inﬂuences inﬂammatory processes and omega-3 polyunsaturated fatty acids (n-3
PUFAs) have known anti-inﬂammatory effects. The balance of pro- and anti-inﬂammatory processes is
coordinated by macrophages and macroautophagy/autophagy has recently emerged as a cellular process
that dampens inﬂammation. Here we report that the n-3 PUFA docosahexaenoic acid (DHA) transiently
induces cytosolic speckles of the autophagic receptor SQSTM1/p62 (sequestosome 1) (described as SQSTM1/
p62-bodies) in macrophages. We suggest that the formation of SQSTM1/p62-bodies represents a fast
mechanism of NFE2L2/Nrf2 (nuclear factor, erythroid 2 like 2) activation by recruitment of KEAP1 (kelch like
ECH associated protein 1). Further, the autophagy receptor TAX1BP1 (Tax1 binding protein 1) and ubiquitinediting enzyme TNFAIP3/A20 (TNF a induced protein 3) could be identiﬁed in DHA-induced SQSTM1/p62bodies. Simultaneously, DHA strongly dampened the induction of pro-inﬂammatory genes including CXCL10
(C-X-C motif chemokine ligand 10) and we suggest that formation of SQSTM1/p62-bodies and activation of
NFE2L2 leads to tolerance towards selective inﬂammatory stimuli. Finally, reduced CXCL10 levels were related
to the improved clinical outcome in n-3 PUFA-supplemented heart-transplant patients and we propose
CXCL10 as a robust marker for the clinical beneﬁts mobilized by n-3 PUFA supplementation.
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Introduction
Low-grade persistent inﬂammation is involved in the initiation and
progression of age-related diseases.1 The individual risk of developing inﬂammation-related diseases clearly varies due to genetic and
environmental differences. The diet is an important factor inﬂuencing the immune system, and a diet rich in marine n-3 PUFAs possesses anti-inﬂammatory properties. Beneﬁcial effects of n-3
PUFAs involve a changed membrane lipid composition and the
promoted synthesis of anti-inﬂammatory and pro-resolving eicosanoids.2 Also, regulatory signaling by n-3 PUFAs has been reported
via, among others, the selective FFAR4/GPR120 (free fatty acid
receptor 4) protein leading to reduced activity of the NFKB
(nuclear factor kappa B) complex and the inﬂammasome.3-5
Macroautophagy (hereafter referred to as autophagy) is a catabolic process that eliminates damaged and excessive intracellular
components by lysosomal degradation.6 Cytoplasmic proteins and
organelles are sequestered by a growing double membrane that
forms an autophagosomal vesicle where the content is degraded
after fusion with a lysosome.7 The autophagic receptor SQSTM1
binds to ubiquitinated cargos and interacts with mammalian
orthologs of yeast ATG8 (autophagy-related 8) on the growing
phagophore membrane leading to selective degradation.8
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Homopolymerization of SQSTM1 is important for efﬁcient
sequestration and turnover of cargo.9 In the case of altered
protein degradation or in response to cellular stresses, the accumulation of SQSTM1 in ubiquitin (Ub)-positive so-called
SQSTM1/p62-bodies (also known as aggresome-like induced
structures [ALIS]) has been described and might provide a temporary form of storage for unfolded proteins to be destroyed.10
Autophagy is important to prevent inﬂammation-prone conditions by maintaining cellular homeostasis but also directly by
selective elimination of invading pathogens (xenophagy)11-13
and the removal of activated inﬂammasomes.14-16
As for autophagic removal of cargo, several inﬂammatory
responses depend on ubiquitination for complex formation,
activation or degradation of the signaling proteins.17 Interestingly, SQSTM1 can also have a pro-inﬂammatory role as its
ubiquitin-binding and polymerizing abilities are necessary for
NF-kB complex activation, suggesting a scaffold function in the
formation of signaling complexes.18,19
We recently reported that physiologically relevant doses of the
n-3 PUFA DHA elevates levels and cytosolic structures of
SQSTM1 and increases turnover of polyubiquitinated proteins in
retinal pigment epithelium cells (ARPE-19), possibly reducing the
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risk of age-related macular degeneration.20 We thus hypothesized
that n-3 PUFAs affect autophagy or ubiquitination to mobilize an
anti-inﬂammatory effect in macrophages. We here report that
human primary monocyte-derived macrophages (MDM) and
RAW264.7 mouse macrophages respond to n-3 PUFAs by induction of SQSTM1 mRNA and protein levels followed by a transient
rise in the number of ALIS like SQSTM1/p62-bodies. While
SQSTM1/p62-bodies are present, there is a clearly dampened
response to lipopolysaccharide (LPS), particularly by a reduced
IFN (interferon) type-I response. Consistently, the reduced secretion of the IFN response protein CXCL10 is evident both in macrophage cell cultures and in blood samples from patients on n-3
PUFA supplements.

Results
The n-3 PUFA DHA induces SQSTM1/p62-bodies
in macrophages
To determine if n-3 PUFAs affect localization of SQSTM1 and
ubiquitinated proteins in macrophages, RAW264.7 cells were
supplemented with 70 mM of the n-3 PUFA DHA, the n-6
PUFA arachidonic acid (AA) or the n-9 monounsaturated fatty
acid oleic acid (OA). The cells were immunostained for
SQSTM1 and conjugated Ub. Confocal inspection showed
formation of SQSTM1/p62-bodies in response to DHA in a
lipid-selective manner. Further, the DHA-induced \SQSTM1/
p62-bodies colocalized more stringently with ubiquitinated
proteins (Fig. 1A) than with MAP1LC3B (microtubule
associated protein 1 light chain 3 b; data not shown), thus representing aggregates rather than autophagosomes. The number
of SQSTM1/p62-bodies and colocalization with Ub transiently
increased up to 16 h and decayed to basal levels after 24 h
(Fig. 1B). Consistently, the level of SQSTM1 and Ub-conjugated proteins also rose in response to DHA supplementation
in RAW264.7 cells in a time- and concentration-dependent
manner (Fig. 1C, S1A and S1B).
Human primary MDM displayed the same lipid-speciﬁc
increase in SQSTM1/p62-bodies and colocalized ubiquitin after
DHA supplementation (Fig. 1D). Automated image analysis
demonstrated that the average number of SQSTM1/p62-bodies
increased up to 24 h after DHA supplementation and decreased
thereafter (Fig. 1E), thus showing the same transient
rise although at a slightly slower kinetics compared to the
mouse macrophages. MDMs similarly demonstrated a selective
increase in the protein levels of SQSTM1 and conjugated Ub in
response to DHA, whereas no increase was observed after treatment with OA or AA (Fig. 1F). Interestingly, the increase in
protein level of SQSTM1 was observed already after 6 h treatment with DHA and was further increased with time up to
24 h (Fig. S1C).
DHA induces formation of detergent-resistant SQSTM1/
p62-bodies degraded by autophagy and activates NFE2L2
DHA supplementation caused a striking translocation of SQSTM1
from a mainly diffuse cytoplasmic location into cytoplasmic bodies
associated with ubiquitinated proteins. Such protein deposits or
ALIS tend to be resistant to detergents.21,22 To determine if DHA-

Figure 1. The n-3 PUFA DHA induces SQSTM1/p62-bodies in macrophages. (A)
Confocal analysis of RAW264.7 cells treated with DHA, OA or AA (70 mM) for 8 h
(scale bars: 10 mm) and (B) automated quantiﬁcation of SQSTM1- and Ub-positive
speckles (< 7000 cells/condition). Data are representative of 3 independent experiments of which 2 were manually counted. (C) Immunoblot (IB) analysis and quantiﬁcation (below) of RAW264.7 cells treated with DHA, OA and AA (70 mM) for 16 h,
n D 4, (repeated measures ANOVA with Dunnett’s). (D) Confocal analysis of MDMs
treated with DHA, OA or AA (70 mM) for 24 h (scale bars: 10 mm) and (E) automated quantiﬁcation of SQSTM1/p62-bodies (< 4000 cells/condition), n D 3
except for 48 h where n D 1. (F) IB and quantiﬁcation (below) of MDMs treated
with DHA, OA and AA (70 mM) for 16 h, n D 5, (Friedman test with Dunn’s).

induced SQSTM1/p62-bodies were detergent resistant, the pellets
that remained after centrifugation in a detergent lysis buffer were
resolved in 8 M urea buffer. Interestingly, the protein level of
SQSTM1 in the detergent-resistant pellet was clearly elevated after
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DHA supplementation in RAW264.7 cells (Fig. 2A) and increased
with centrifugation speed (Fig. S1D). Thus, for the remainder of
the study, cells were lysed directly in 8 M urea buffer to avoid losing
part of the SQSTM1 pool.

SQSTM1 is continuously turned over by autophagy.21
A combined treatment with DHA and the lysosomal inhibitor
baﬁlomycin A1 (BafA1) caused an additive increase in the protein level of SQSTM1 in the detergent-resistant fraction.

Figure 2. DHA induces formation of detergent-resistant SQSTM1/p62-bodies degraded by autophagy and activates NFE2L2. IB of soluble and insoluble fractions of
RAW264.7 cells treated with DHA (70 mM) with or without BafA1 (100 nM) for (A) 16 h or (B) 8 h followed by 12 h incubation in fresh medium (Med) with or without
BafA1. Hmw SQSTM1 was visualized by long exposure (exp). (C) IB of RAW264.7 cells treated with DHA, OA or AA (70 mM) with or without BafA1 (100 nM) for 8 h. Data
are representative of 3 independent experiments. (D) FACS analysis of ROS levels in RAW264.7 cells at different time points after DHA (70 mM) using a ﬂuorescent CMH2DCFDA probe, n D 3, (paired t-test). (E) Confocal analysis of RAW264.7 cells treated with DHA, OA or AA (70 mM) for 3 h (scale bars: 10 mm). Representative images are
shown, n D 3. (F) IB analysis of cytosolic (Cyt) or nuclear (Nuc) fractions after 3 h DHA with or without addition of 5 mM NAC or 6 h DHA and quantiﬁcation of cytosolic
SQSTM1 levels and nuclear NFE2L2 levels (below), n D 3, (repeated-measures ANOVA with Dunnett’s). (G) IB analysis and quantiﬁcation (right) of RAW264.7 cells after 3 h
DHA with or without addition of 5 mM NAC, n D 3, (repeated-measures ANOVA with Dunnett’s). (H) IB analysis and quantiﬁcation (right) of MDM after 3 h DHA with or
without addition of 5 mM NAC, n D 3. (I) QRT-PCR analysis of NFE2L2 target genes SQSTM1, HMOX1, NQO1 and SLC7A11 in vehicle- and DHA-treated MDMs, n D 5
(Friedman test with Dunn’s).
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However, no concurrent increase in the protein level of
MAP1LC3B was observed after BafA1 treatment (Fig. 2A).
This shows that autophagy can be elevated as measured by the
number of SQSTM1 proteins degraded per cell, without affecting the turnover of MAP1LC3B-II. Interestingly, DHA also
induced some slower migrating proteins detected by SQSTM1
antibodies in both RAW264.7 cells and MDMs (Fig. 2A and
S1E), which were clearly reduced by siRNA targeting SQSTM1
(Fig. S1E). The same migration pattern was detected using 5
different SQSTM1-speciﬁc antibodies in ARPE-19 cells (Fig.
S1F). The 2 most prominent of these additional SQSTM1 bands
migrated at approximately 70,000 and 120,000, of which the
latter is indicated as high molecular weight (hmw) SQSTM1.
Each of the additional bands accounted for approximately 5%
of total SQSTM1 levels in DHA- and BafA1-treated cells. The
hmw SQSTM1 showed the same concentration- and timedependent increase as unmodiﬁed SQSTM1 (Fig. S1A and
S1B), was especially prominent in the detergent-resistant fraction and was strikingly elevated after cotreatment with DHA
and BafA1 (Fig. 2A). Importantly, hmw SQSTM1 could be
depleted from the soluble fraction and enriched in the detergent-resistant pellet by increasing centrifugation speed (Fig.
S1D). The elevated protein levels of SQSTM1 and hmw
SQSTM1 were of a transient nature. Removal of DHA and
incubation for an additional 12 h in fresh medium clearly
reversed the DHA-induced effects (Fig. 2B). The reduction in
SQSTM1 protein levels could be blocked by adding BafA1 in
the recovery medium, suggesting turnover by autophagy. As
for the SQSTM1/p62-bodies, hmw SQSTM1 was mainly
induced by DHA (Fig. 2C). Together, these results demonstrate
that DHA induces SQSTM1 protein levels, posttranslational
modiﬁcations and translocation of the protein into detergentresistant cytoplasmic bodies in a lipid-selective manner. Furthermore, the formed structures are of a transient nature and
degraded by autophagy.
The SQSTM1 gene is induced in response to cellular stress
such as reactive oxygen species (ROS) via the transcription factor NFE2L223,24 and ROS are involved in the formation of
ALIS.22 We have previously found that DHA induced transient
ROS and NFE2L2 nuclear translocation in ARPE-19 cells.20
Also in macrophages, DHA induced ROS at time points preceding the increase in SQSTM1 protein levels as measured by a
ﬂuorescent ROS DCF probe (Fig. 2D). Nuclear translocation of
NFE2L2 could be observed by confocal microscopy (Fig. 2E)
and immunoblotting of cytosolic (Cyt) and nuclear fractions
(Nuc) (Fig. 2F). Consistent with a NFE2L2-mediated anti-oxidative response, the NFE2L2 target protein HMOX1 (heme
oxygenase 1) showed a similar increase as SQSTM1 in response
to DHA (Fig. 2G). Both the DHA-induced ROS increase, translocation of NFE2L2 and rise in SQSTM1 and HMOX1 protein
levels was strongly reduced by a pretreatment with the ROS
scavenger N-acetyl cysteine (NAC) (Fig. 2D, 2F and 2G). Similarly, in MDMs, HMOX1 protein levels increased in response
to DHA, but clearly less so in the presence of NAC (Fig. 2H
and S1C). Importantly, DHA induced the transcriptional activity of NFE2L2 as measured by increased mRNA levels of its target genes SQSTM1, HMOX1, NQO1 (NAD[P]H quinone
dehydrogenase 1) and SLC7A11 (solute carrier family 7 member 11) in MDMs (Fig. 2I).
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DHA strongly reduced expression of CXCL10
by affecting several signaling pathways
Anti-inﬂammatory effects of n-3 PUFAs have been determined
as reduced induction of diverse pro-inﬂammatory cytokines.
To identify putative anti-inﬂammatory effects of DHA in our
system, we determined if macrophages respond differently to
LPS when pretreated with DHA for 16 h. This time point was
used because the number of SQSTM1/p62-bodies peaked at
this time. As an initial screen, NanoString technology was used
to quantify the levels of 579 inﬂammation-related transcripts in
DHA-pretreated MDMs from 2 donors that were stimulated
with LPS for 3 h. Of these genes, 163 were selected as LPSresponsive transcripts as their mRNA levels increased more
than 1.5-fold in each donor. Among those, 148 were downregulated and 15 upregulated by DHA pretreatment (Fig. 3A and
Table S1). The clearest reduction was seen for CXCL9, CXCL10
and CXCL11, a subfamily of chemokines that are highly inducible by IFNG/IFNg and signal through their common receptor
CXCR3 (C-X-C motif chemokine receptor 3)25 to attract additional immune cells. CXCL10 is the best studied of these and is
implicated in diseases with underlying inﬂammation.26 Of
note, classical NFKB target genes including TNF (tumor necrosis factor), IL1B (interleukin 1 b) and IL6, displayed only minor
or opposite changes by DHA pretreatment in this screen. These
observations were validated by qRT-PCR as in primary macrophages isolated from 5 different healthy donors, where DHA
pretreatment caused an approximately 80% reduction in the
LPS-induced expression of CXCL10 in a lipid selective manner
(Fig. 3B and 3C). The lowered mRNA levels of CXCL10 were
accompanied by reduced secretion of CXCL10 measured by
ELISA (Fig. S2A). Also in RAW264.7 macrophages, we
observed a signiﬁcant decrease in the induction of Cxcl10 but
also Tnf mRNA after DHA pretreatment and stimulation with
LPS for 3 h (Fig. S2B). We thus asked if this difference could be
explained by different kinetics of TNF induction in both systems. Indeed, in MDMs, DHA pretreatment caused reduction
in the LPS induction of TNF mRNA levels at earlier time points
and was more pronounced at the peak of TNF expression at 2 h
of LPS stimulation (Fig. S2C). The DHA-mediated decrease in
CXCL10 was not limited to induction by LPS but could also be
seen with other inducers of IFN signaling such as TLR3 (toll
like receptor 3) ligand poly(p)(I:C) and the synthetic TLR8
ligand pU (Fig. S2D). Overall, these data show that DHA particularly dampens type-I IFN responses, including CXCL10
induction, in a lipid-selective manner in mouse and human
macrophages.
The synthesis of CXCL10 is regulated at the transcriptional
level by the transcription factors NFKB complex, IRF3 (interferon regulatory factor 3), IRF1 and STAT1 (signal transducer
and activator of transcription 1).27,28 To determine which initial
signaling axis DHA affects, phosphorylation of IRF3 (S386) and
the NFKB subunit RELA/p65 (S536) was analyzed. DHA pretreatment led to reduced levels of phosphorylated IRF3 in
response to LPS in MDMs while no change in phosphorylation
of RELA (S536) was observed (Fig. 3D). We also checked subunit NFKB1/p105 (S933) of the heterodimeric NFKB complex,
which showed a reduced phosphorylation in response to LPS
after DHA pretreatment (Fig. S2E). In RAW264.7 cells, DHA
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Figure 3. The n-3 PUFA DHA strongly reduced expression of CXCL10 by affecting several signaling pathways. (A) MDMs were treated with DHA (70 mM) for 16 h before
stimulation with LPS (100 ng/ml) for 3 h. Transcript levels of 579 genes (nCounter GX Human Immunology kit assay) were determined. Transcripts that were more than
1.5-times increased by LPS in both donors were selected and the fold change between vehicle- and DHA-treated cells calculated, mean § SD, n D 2. (B) QRT-PCR analysis
of CXCL10 and (C) TNF in MDM treated with DHA, OA or AA for 16 h and LPS for 3 h, n D 5 (Friedman test with Dunn’s). (D) IB analysis and quantiﬁcation of IRF3 and
RELA phosphorylation in MDMs treated with DHA, OA or AA for 16 h and LPS for 1 h, n D 5. (Friedman test with Dunn’s), of (E) TBK1, IKBKB, STAT1 and STAT3 phosphorylation in MDMs treated with DHA, OA or AA for 16 h and LPS for 1 or 4 h, n D 5 (Wilcoxon matched-pairs signed rank test, one-tailed) and of (F) IRF1 and RELA in cytosolic
(Cyt) and nuclear (Nuc) fractions in MDMs treated with DHA, OA or AA for 16 h and LPS for 2 or 4 h, n D 5 (Wilcoxon matched-pairs signed rank test). (G) IFNB1 mRNA levels after incubation with DHA for 16 h and LPS for 2 h, n D 6 (Wilcoxon matched-pairs signed rank test).
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similarly reduced the phosphorylation of IRF3 (S396) and
NFKB1 (S933) but not RELA (S536) (Fig. S2F). We then analyzed the phosphorylated, active forms of IKBKB/IKKb (inhibitor of nuclear factor kappa B kinase subunit b) and TBK1
(TANK binding kinase 1) that are upstream kinases of classical
NFKB and IRF3 signaling, respectively.29 Surprisingly, in
MDMs, DHA pretreatment decreased the LPS-induced levels
of phosphorylated IKBKB but not TBK1 (Fig. 3E).
Besides direct induction via IRF3 and NFKB, CXCL10 is
induced as a secondary response gene in an IFN-dependent
manner. After TLR4 stimulation, secreted IFNs bind to
IFNAR1 (interferon a and b receptor subunit 1) in an autocrine manner and activate JAK2 (Janus kinase 2)-STAT1 signaling and synthesis of CXCL10.30,31 We found approximately
50% reduced IFNB and IFNG mRNA induction after DHA pretreatment in the NanoString data (Table S1), and could conﬁrm
limited induction of IFNB mRNA 2 h after LPS stimulation in
DHA-pretreated MDMs (Fig. 3G). Moreover, inhibition of
IFNAR1 suppressed LPS-mediated CXCL10 induction similarly
to DHA and limited further reduction by DHA (Fig. S2G),
demonstrating that the n-3 PUFA supplementation also dampened autocrine IFN signaling. Consistently, DHA pretreatment
decreased the phosphorylation of both STAT1 and STAT3
when induced by 4 h LPS stimulation; however, this was more
pronounced and signiﬁcant only for STAT3 (Fig. 3E). Also in
RAW264.7 macrophages DHA but not OA or AA pretreatment
dampened the activation of STAT1 (Fig. S2F).
Of note, in the mRNA expression screen DHA pretreatment
also reduced the LPS induction of IRF1, IRF4, IRF7 and IRF8
(Table S1). IRF1 is strongly induced in response to IFN and
other cytokines32 and binds to the CXCL10 promotor.33 Therefore, we investigated if nuclear translocation of IRF1 is affected
by DHA. Immunoblotting showed a clear increase of nuclear
IRF1 levels after 2 h and 4 h of LPS stimulation that was clearly
reduced in DHA-pretreated MDMs. RELA could also be
detected in nuclear lysates after 2 h of LPS stimulation, but was
unchanged by DHA-pretreatment (Fig. 3F). In addition, confocal image analysis showed increased intensity of nuclear IRF1
staining at 2 h of LPS stimulation, which was limited by DHA
pretreatment while number, area and maximum radius of
SQSTM1/p62-bodies were augmented (Fig. S2I).
The DHA-mediated inﬂammatory tolerance is related
to the formation of SQSTM1/p62-bodies
The results presented above demonstrate that DHA selectively
induced the formation of SQSTM1/p62-bodies or ALIS and
reduced LPS-induced CXCL10 expression. To assess the relation between both observations, MDMs were pretreated with
DHA for increasing times and ﬁnally stimulated with LPS for
1 h. Interestingly, the decrease in phosphorylated IRF3 and
IKBKB was clearest when SQSTM1 levels were most induced
(Fig. 4A).
We thus speculated that formation of SQSTM1/p62-bodies
could play a role in establishing tolerance towards inﬂammatory signaling. We ﬁrst checked if impaired formation of
SQSTM1/p62-bodies would impair downregulation of CXCL10
by DHA. As shown above, the induction of SQSTM1 by DHA
could be prevented by adding the anti-oxidant NAC.

Figure 4. The DHA-mediated inﬂammatory tolerance is related to the formation of
SQSTM1/p62-bodies. (A) IB analysis of MDMs treated with DHA (70 mM) for the
indicated times followed by LPS for 1 h. The quantiﬁcation (below) represents
mean fold changes § SEM of DHA C LPS compared to vehicle C LPS on a log
scale, n D 6, (Friedman test with Dunn’s). (B) QRT-PCR analysis of CXCL10 levels in
MDM after 16 h DHA with and without addition of 5 mM NAC followed by 3 h LPS,
n D 3, (repeated-measures ANOVA with Dunnett’s). (C) QRT-PCR analysis of
CXCL10 in SQSTM1 siRNA-transfected MDMs treated with DHA for 16 h and LPS for
3 h, n D 5, (Friedman test with Dunn’s). (D) IB analysis of IRF3, RELA and IKBKB
phosphorylation in control and SQSTM1 knockdown MDMs, n D 6 (Friedman test
with Dunn’s). (E) CXCL10 protein levels in Sqstm1C/C (n D 8) and sqstm1¡/¡
(n D 10) male mice were measured by ELISA. Serum was analyzed at baseline and
at 3 and 6 h after challenge with 3.5 mg/g LPS. ND, not detected.
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Treatment with NAC before stimulation with LPS limited
CXCL10 induction to a similar extent as DHA alone, showing
little further effect of the combination of NAC and DHA
(Fig. 4B). As activation of NFE2L2 might also play a role in this
observation, we treated MDMs with L-sulforaphane (L-Sulf),
an established activator of NFE2L2. Treatment with L-Sulf
abolished LPS-induced CXCL10 expression (Fig. S2H).
SQSTM1 is known to be necessary for the formation of ALIS.22
Thus we speculated that knockdown of SQSTM1 would interfere with the formation of SQSTM1/p62-bodies and the downregulation of CXCL10 by DHA. SQSTM1 was shown to have
anti-inﬂammatory12,16,34 but also pro-inﬂammatory effects
itself.18,19 In line with the pro-inﬂammatory role of SQSTM1,
the SQSTM1-depleted MDMs displayed reduced expression of
CXCL10 in response to LPS (Fig. 4C). SQSTM1-depleted
MDMs, also showed decreased levels of phosphorylated IKBKB
and IRF3, although not signiﬁcant for IRF3, and no further
decrease by DHA treatment (Fig. 4D). Similarly, a trend of
decreased CXCL10 secretion after 3 and 6 h LPS challenge was
observed in Sqstm1 depleted (sqstm1¡/¡) mice (Fig. 4E), suggesting that SQSTM1 is involved in the induction of CXCL10
signaling in vivo. Together these data indicate that SQSTM1 is
necessary for full induction of CXCL10 expression, whereas the
formation of SQSTM1/p62-bodies is important for the LPS tolerance induced by n-3 PUFAs like DHA.
KEAP1 is sequestered in DHA-induced SQSTM1/p62-bodies
and contributes to inﬂammatory tolerance
The obtained results indicated that the DHA-mediated formation of SQSTM1/p62-bodies dampened LPS-induced signaling
in macrophages. We therefore aimed to characterize the proteins recruited into the DHA-induced SQSTM1/p62-bodies
that mediate the tolerance towards inﬂammatory stimuli.
The previously established centrifugation protocol was used
for partial puriﬁcation of DHA-induced SQSTM1/p62-bodies
from RAW264.7 cells and the isolated proteins were identiﬁed
by mass spectrometry (MS). Proteins were considered as DHAspeciﬁcally enriched in the detergent insoluble fraction if they
were more abundant in DHA-treated samples versus vehicle as
well as further elevated in samples cotreated with DHA and
BafA1 versus BafA1 alone. Using these criteria, SQSTM1 was
clearly the most abundant DHA- and BafA1-induced protein
in the detergent-resistant fraction (Fig. S3A). Interestingly,
TAX1BP1 and KEAP1 were the second and third most prominent proteins recruited into the detergent-resistant fraction in
response to DHA and clearly further accumulated by inhibiting
lysosomal degradation. However, since this analysis was only
based on different detergent solubility, the detected proteins
could reside in many different compartments and structures. In
order to limit the detection of proteins to DHA-induced partners of SQSTM1, we performed immunoprecipitation (IP) of
endogenous SQSTM1 from vehicle treated or DHA-stimulated
RAW264.7 cells and identiﬁed copuriﬁed interaction partners
by MS (Fig. S3B). KEAP1 and TAX1BP1 were the only proteins
that were found both in the detergent-resistant fraction as well
as co-immunoprecipitated with SQSTM1 and were thus considered as located to SQSTM1-containing protein bodies in a
DHA-induced manner. These interactions were validated in

MDMs where KEAP1 and TAX1BP1 co-immunoprecipitated
with SQSTM1 (Fig. 5A). Apparently, DHA did not change the
afﬁnity of TAX1BP1 or KEAP1 for SQSTM1 but the association increased proportionally with the lipid-induced rise in
SQSTM1 protein level.
TAX1BP1 is an autophagy receptor involved in xenophagy35 and could bind SQSTM1 indirectly via ubiquitin.
KEAP1 mediates ubiquitination and degradation of NFE2L2
under normal unstressed conditions36 and has been suggested to contribute to degradation of protein aggregates.37
Also, the association of KEAP1 with SQSTM1/p62-bodies
has been shown to stabilize and activate NFE2L2.38 NFE2L2
activation, besides its anti-oxidative function, plays an
important role in the regulation of inﬂammation.39-42 In
addition, we recently demonstrated a role for KEAP1 in the
regulation of inﬂammatory signaling, via ubiquitination and
degradation of IKBKB.43 Intriguingly, TAX1BP1 has been
implicated as a negative regulator of NFKB signaling due to
the recruitment of the ubiquitin-editing enzyme TNFAIP3.44
Also, IRF3-dependent signaling is negatively regulated by
TAX1BP1 and TNFAIP3.45,46 Immunostaining of MDMs
demonstrated that both KEAP1 and TAX1BP1 are located
in DHA-induced SQSTM1/p62-bodies (Fig. 5B and S3C). In
contrast to MS data and IPs, by confocal analysis also
TNFAIP3 could be detected in SQSTM1/p62-bodies (Fig.
S3C) indicating that this protein interacts with the
SQSTM1/p62-bodies in a more transient manner. Importantly, about 20% of KEAP1 was found in insoluble aggregates and corresponded well with the fraction of SQSTM1
that translocated to the detergent-resistant fraction in
response to DHA treatment (Fig. 5C). As the sequestration
of KEAP1 by SQSTM1 has previously been shown to lead
to NFE2L2 activation, we analyzed the mRNA level of
NQO1 in SQSTM1 knockdown cells treated with LPS and
DHA. In line with an important role of SQSTM1 in activation of NFE2L2 in the presence of DHA, NQO1 mRNA (as
opposed to CXCL10) was signiﬁcantly induced by DHA in
a SQSTM1-dependent manner (Fig. S3D).
We next asked if recruitment of KEAP1, TAX1BP1 or
TNFAIP3 into SQSTM1/p62-bodies has a repressive function on CXCL10 signaling. MDMs were transfected with
siRNA targeting KEAP1, TAX1BP1 and TNFAIP3 and
decreased protein or mRNA levels were observed, albeit
TNFAIP3 was less efﬁciently reduced (Fig. S3E, S3F). As
KEAP1 is the repressor of NFE2L2, the expression of
NFE2L2 target genes was analyzed in KEAP1-depleted
MDMs and showed at least partial activation of NFE2L2
with induction of NQO1 and SLC7A11 (Fig. S3G). Depletion of TAX1BP1 or TNFAIP3 did not have any signiﬁcant
effect on CXCL10 levels (Fig. S3H and S3I), whereas depletion of KEAP1 signiﬁcantly limited the ability of DHA to
dampen LPS-induced CXCL10 expression (Fig. 5D). When
directly comparing the reduction by DHA-pretreatment on
LPS-induced CXCL10 expression, there was a signiﬁcant
difference in the presence or absence of KEAP1 (76.4% §
16.4% vs 44.8% § 22.2% respectively, with less effective
DHA pretreatment in KEAP1-depleted cells in all 5 replicates) (Fig. 5D, right). The same pattern could be seen for
mRNA induction of CXCL11 (Fig. 5E), another chemokine
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The plasma level of CXCL10 is reduced by n-3 PUFA
supplementation but increased in the placebo group
in hypertensive heart transplant recipients.
According to our results, we expected n-3 PUFA supplementation to be most effective in conditions with chronically elevated CXCL10 levels. Therefore, we obtained plasma samples
of the heart transplant patients in the OmaCor-study, as elevated levels of CXCL9 and CXCL10 are known as causes for
transplant rejection.47,48 Plasma samples of these patients were
taken at baseline after transplantation and following 12 mo
with daily administration of n-3 PUFA (DHA and eicosapentaenoic acid) or placebo (corn oil). This clinical trial documented an improved clinical outcome from intake of n-3
PUFAs compared to the placebo group as measured for example by lowered blood pressure.49 However, a corresponding
reduction in any inﬂammatory mediators in response to the
n-3 PUFAs have not been previously found. In fact, TNF was
slightly increased by n-3 PUFA treatment in this study.50 We
measured CXCL10 by ELISA on those patient plasma samples
and found the CXCL10 levels in the placebo group increased
after transplantation in line with a nonresolved inﬂammation
in these patients. Conversely, in total agreement with the
results from the cell-based assays, n-3 PUFA administration
signiﬁcantly decreased CXCL10 levels after transplantation
(Fig. 6, left). In line with our expression analyses, the IL6 levels did not differ between the placebo and the n-3 PUFA
group (Fig. 6, right). These data suggest that n-3 PUFA supplementation dampens conditions driven by sterile inﬂammation and that a reduced type-I interferon response, including
lowered CXCL10, represents potent markers for such beneﬁcial effects.
To relate this observation to our in vitro mechanism, we
wanted to assess NFE2L2 activation in our patient material.
IL36G is a direct target gene of NFE2L2 and upregulated by
NFE2L2 activation.51 We measured IL36G levels as read-out
for NFE2L2 and found an inverse correlation between CXCL10
and IL36G levels at baseline (r D -0.57, p < 0.05), suggesting
that NFE2L2 activity contributes to limit CXCL10 levels (data
not shown).
In summary, our data are consistent with an important role
of DHA-induced SQSTM1 polymerization and resulting
NFE2L2 activation in the reduction of serum levels of CXCL10.

Figure 5. KEAP1 is sequestered in DHA-induced SQSTM1/p62-bodies and contributes to inﬂammatory tolerance. (A) IP of SQSTM1 from MDMs treated with DHA for
16 h and IB analysis of KEAP1 and TAX1BP1; INPUT (10%). Data are representative
of 3 independent experiments. (B) Immunostaining for SQSTM1 and KEAP1 in
MDMs treated with DHA for 24 h (scale bars: 10 mm). (C) IB analysis and quantiﬁcation (below) of SQSTM1 and KEAP1 in soluble and insoluble fractions from
RAW264.7 cells after 16 h DHA, n D 4 (repeated measures ANOVA). (D) QRT-PCR
analysis of CXCL10 or (E) CXCL11 in KEAP1 siRNA-transfected MDMs treated with
DHA for 16 h and LPS for 3 h, n D 5 (Friedman test with Dunn’s). (right) Comparison of the downregulating effect of DHA in control or KEAP1 siRNA-treated MDMs
from (D) or (E) respectively, n D 5 (Mann Whitney test).

strongly affected by DHA. Thus, the formation of SQSTM1/
p62-bodies and sequestration of KEAP1 plays a role in the
DHA-mediated inﬂammatory tolerance in macrophages.

Figure 6. The plasma level of CXCL10 is reduced by n-3 PUFA supplementation but
increased in the placebo group in hypertensive heart transplant recipients. The
concentration of CXCL10 (left) and IL6 (right) was determined by ELISA in plasma
of hypertensive heart transplant recipients isolated at baseline and after 12 mo of
daily supplementation of placebo (corn oil, n D 19) or n-3 PUFAs (n D 16).
Horizontal lines represent mean plasma levels. p < 0.01, p < 0.05 and nonsigniﬁcant (n.s.) were all vs baseline.
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Discussion
With increasing evidence of the health beneﬁts and antiinﬂammatory effects of n-3 PUFAs, these lipids represent a
valuable tool to identify cellular mechanisms of maintenance
and homeostasis. In response to polyunsaturated fatty acids, we
found that macrophages dampened pro-inﬂammatory signaling as evident by reduced transcription of a large number of
inﬂammation-related genes after LPS stimulation. The effects
were clearest for type-I IFN-related responses with CXCL10 as
the most prominent. Importantly, CXCL10 protein levels were
reduced both in the media of cultured macrophages and in
blood samples of patients supplemented with n-3 PUFAs. We
found that SQSTM1/p62-bodies, protein bodies containing the
autophagic cargo receptor SQSTM1, are formed in response to
the n-3 PUFA DHA. The ROS sensor KEAP1, the autophagy
receptor TAX1BP1 and the ubiquitin-editing enzyme TNFAIP3
could be found in SQSTM1/p62-bodies. Of these proteins,
depletion of KEAP1 led to limited effects of DHA supplementation. We suggest that the DHA-mediated formation of
SQSTM1/p62-bodies and recruitment of KEAP1 represent a
fast mechanism for NFE2L2 activation, playing a role in the
regulation of inﬂammatory signaling in macrophages. Thus,
the data point to an important balance where dietary lipids
inﬂuence endogenous and exogenous antioxidants in controlling inﬂammatory signaling in macrophages.
SQSTM1 is known to form aggregates and to sequester ubiquitinated proteins into speckles also described as ALIS.21 These
structures were initially shown in dendritic cells during maturation52 and may occur in response to various cellular stresses
such as LPS stimulation, infection, oxidative stress or proteasomal inhibition.53 DHA supplementation led to a transient
increase in detergent-resistant SQSTM1/p62-bodies associated
with ubiquitinated proteins. Sequestration of potentially harmful and misfolded proteins might help in detoxiﬁcation of the
cytoplasm and could disarm inﬂammation-prone conditions.
Interestingly, Sergin et al. reported a protective role of SQSTM1
in the sequestration of ubiquitinated inclusions in atherosclerosis, as deletion of the gene encoding SQSTM1 caused diffuse
distribution of ubiquitinated and misfolded proteins and had
worse outcomes.54
ALIS are reported to be degraded via the autophagic-lysosomal pathway.8,22 The increase in SQSTM1/p62-bodies
observed after DHA supplementation was transient and reversible in case of functional autophagosome-lysosome fusion, indicating that DHA-induced SQSTM1/p62-bodies are handled via
lysosomal degradation. Further, our results suggest that the
autophagic clearance of tightly packed protein speckles of
SQSTM1 and associating proteins can be elevated without any
major changes in basal autophagy as measured by the turnover
of MAP1LC3B-II. SQSTM1 can homopolymerize55 and 1 molcule of MAP1LC3B likely intereacts with a chain of SQSTM1.8
Thus, the autophagic turnover of SQSTM1 may increase by
stimuli that increase polymerization without any detectable
change in MAP1LC3B degradation. How homopolymerization
of SQSTM1 is regulated represents an interesting question as
the ability of cargo receptors to polymerize may be an important regulatory step for autophagy. In this regard, we observed
posttranslational modiﬁcations of SQSTM1, as seen by slower

migrating protein forms in response to n-3 PUFA supplementation. SQSTM1 can form covalently crosslinked oligomers in
response to ROS-inducing drugs in a PB1-dependent manner.56
We ﬁnd that DHA stimulates the formation of hmw SQSTM1,
which might be explained by the generation of ROS or direct
crosslinking of SQSTM1 as DHA is a highly reactive and easily
oxidized molecule.57 Also, a transient increase in hmw
SQSTM1 as well as activation of NFE2L2 has been reported for
other PUFAs.58 Thus, covalent crosslinking of SQSTM1 dimers
can be an important mode of regulation of protein turnover
after oxidative stress also under noncytotoxic conditions. Also
our data indicate that crosslinked SQSTM1 in protein aggregates mediates a transient storage of damaged proteins that are
degraded by autophagy after new synthesis of unmodiﬁed
SQSTM1. On the contrary, diets containing already oxidized n3 PUFAs increase inﬂammatory signaling,59 suggesting that the
original reactivity of the molecule might be needed for beneﬁcial effects. In this regard, a balanced level of exogenous
anti-oxidants in the n-3 PUFA formulation seems important to
prevent oxidation of the lipid but also allow activation of
endogenous anti-oxidative responses.
We observed activation of NFE2L2 with coinciding induction of its target genes SQSTM1, HMOX1, NQO1 and SLC7A11
during DHA treatment in total agreement with what we
recently reported also in nontransformed, diploid epithelial
cells.20 The interaction of SQSTM1 and KEAP1 and the sequestration of KEAP1 into SQSTM1/p62-bodies has been shown as
an alternative way to liberate and activate NFE2L2.60,61 We
here describe the formation of SQSTM1/p62-bodies with
sequestration of a substantial fraction of KEAP1 in response to
the physiological stimuli DHA as a fast mechanism for NFE2L2
activation. In this line, depletion of SQSTM1 or KEAP1 modulated NFE2L2 activation and impaired the DHA-mediated
anti-inﬂammatory effects. NFE2L2 has been ﬁrmly established
as a regulator of inﬂammation.40,62 We found that activation of
NFE2L2 by an established inducer strongly limited LPSinduced CXCL10 expression. nfe2l2 knockout mice show
increased mortality and inﬂammatory markers such as phosphorylated IRF3 during septic shock,41 including augmented
expression of CXCL10.39 In humans, NFE2L2 polymorphisms
are associated with the development of gastric mucosal inﬂammation63 and increased risk for acute lung injury characterized
by inﬂammation.64 Also, NFE2L2 and expression of HMOX1
have been implicated in the development of a macrophage phenotype with lower inﬂammatory signature.42,65,66 Finally, in
nfe2l2 knockout mice, the anti-inﬂammatory effects of DHA
have been shown to be NFE2L2-dependent.67
Interestingly, exposure to LPS has not only been found to
induce ALIS, but also to establish endotoxin tolerance, limiting further inﬂammatory signaling in septic patients68 and
monocytes.69 In addition, Vasconcellos et al. recently demonstrated that free heme and iron, as a result of hemolysis,
induce ALIS as a way to maintain homeostasis.70 These
reports suggest that under physiological conditions transient
formation of SQSTM1/p62-bodies could represent a beneﬁcial
mechanism of NFE2L2 activation. Of interest, a role of
KEAP1 in the clearance of SQSTM1/p62-bodies has been
reported37 while CXCL10 secretion is increased in autophagydeﬁcient cells.71 Thus, the presence of KEAP1 in SQSTM1/
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p62-bodies might promote their autophagic degradation, limiting CXCL10 expression. Furthermore, we have previously
shown that KEAP1 dampens inﬂammatory signaling by degradation of IKBKB in mycobacterial infection,43 thus KEAP1
might have additional NFE2L2-independent ways of regulating inﬂammation.
Anti-inﬂammatory effects of n-3 PUFAs have been established on the expression of many cytokines, but differ between
model systems. By taking a broad approach to screen for quantitative differences of more than 500 inﬂammation gene products, we could identify CXCL10 as the most clearly dampened
cytokine after n-3 PUFA treatment. This cytokine was consistently lowered at both the mRNA level and as a secreted protein
in mouse macrophages, primary human macrophages and in
heart transplant patients in a lipid-selective manner. Increased
intake of DHA has been found to reduce the level of CXCL10
in vivo in a mouse model of stress-induced dry eye.72 Also, n-3
PUFA supplementation decreases the CXCL10 concentration
in hepatitis C patients.73 Of note, one clinical trial suggested
that n-3 PUFAs from ﬂaxseed augment the expression of
NQO1 in cystic ﬁbrosis patients,74 making it possible to speculate that the formation of SQSTM1/p62-bodies and activation
of NFE2L2 as we have shown in macrophages might also play a
role to limit CXCL10 during clinical DHA supplementation.
This is further supported by the inverse correlation that
we found in our patient samples between CXCL10 and the
NFE2L2-controlled cytokine IL36G.51 Importantly, we here
show lowered CXCL10 levels to correlate with the better clinical outcome seen in n-3 PUFA-supplemented heart transplant
patients. This study used an n-3 PUFA formulation with the
minimum of exogenous anti-oxidants. Our data show that
exogenous anti-oxidants can interfere with the activation of the
anti-oxidative response by DHA and might thus prevent beneﬁcial health effects. Patients with cardiovascular diseases,
inﬂammatory disorders, microbial pathologies and Alzheimer
disease also have increased CXCL10 levels as a consequence of
persistent inﬂammation.26,75 Thus, CXCL10 might be a useful
marker for anti-inﬂammatory effects of n-3 PUFAs in these
pathological conditions.
In summary, we identify CXCL10 as a robust marker for the
inﬂammatory tolerance established by n-3 PUFAs in clinical
settings with low-grade chronic inﬂammation. We propose
that lipid-induced transient activation of the cellular stress
response, as seen by activation of NFE2L2 by formation of
SQSTM1/p62-bodies with association of KEAP1, counteracts
the signals that drive the type-I interferon response and in particular the synthesis of CXCL10. The identiﬁed effects of n-3
PUFAs on interferon signaling contribute to our understanding
of how the risk of inﬂammation- and age-related diseases can
be modulated by dietary lipids.

Materials and methods
Cell culture and stimulation
RAW264.7 macrophages (ATCC, TIB71) were cultured in
RPMI (Sigma, R8758) with 10% fetal bovine serum (Gibco,
10270–106) and gentamicin (0.05 mg/mL; Gibco, 15710049).
ARPE-19 (ATCC, CRL-2302) were cultured in DMEM:F12

1673

(Sigma, D8437). PBMC were isolated from buffy coats
(obtained from the blood bank of St. Olavs Hospital, Trondheim, Norway) by a LymphoprepTM (AXIS-SHIELD PoC AS,
1114547) density gradient. Monocytes were selected by plastic
adherence and differentiated into monocyte-derived macrophages (MDM) by culture in RPMI with 30% human serum for
5 d, followed with 10% human serum during experiments. All
cells were maintained in 5% CO2 at 37 C.
Docosahexaenoic acid (DHA; Cayman, 90310), oleic acid
(OA; Cayman, 90260) and arachidonic acid (AA; Cayman,
90010) were added to prewarmed complete medium (70 mM)
before being given to the cells. Absolute ethanol was used as
control in all experiments.
Other reagents used were: baﬁlomycin A1 (BafA1; Sigma,
B1793), LPS (InvivoGen, tlrl-3pelps), L-sulforaphane (L-Sulf;
Sigma-Aldrich, S6317), pU complexed with pL-Arg (Sigma
Aldrich, P7762) at a 1:1 ratio (w:w), p(I:C) transfected with Lipofectamine RNAiMAX (Invitrogen, 13778150), and N-acetylcysteine (NAC; Sigma, A9165).
Antibodies used were: ATCB/b actin (Abcam, ab6276);
COX4I1/COXIV (Abcam, ab33985); GAPDH (Merck Millipore,
CB1001); HMOX1 (Enzo Life Sciences, ADI-OSA-110); IRF3
(Santa Cruz Biotechnology, sc-9082); KEAP1 (Proteintech,
10503–2-AP); KEAP1 (Santa Cruz Biotechnology, E20);
LMNA/lamin A/C (Santa Cruz Biotechnology, sc-6215); monoand polyUb conjugates (FK2; Biomol, PW8810); SQSTM1 (Progen, GP62-C); phospho-IRF3 (S386; Abcam, ab76493); STAT1
(BD Biosciences, 610116); TNFAIP3/A20 (Santa Cruz Biotechnology, sc-166692). The following were from Cell Signaling
Technology: IKBKB/IKKb (8943); IRF1 (4302); IRF3 (4302S),
MAP1LC3B (3868); MAPK1/3/p44/42 (9107); RELA/p65 (3034);
phospho-CHUK/IKBKB/IKKa/b (S176/180; 2697); phosphoIRF3 (S396; 4302); phospho-NFKB2/p105 (S933; 4806);
phospho-RELA/p65 (S536; 3033); phospho-STAT1 (Y701; 7649);
phospho-STAT3 (Y705; 9145); phospho-TBK1 (S172; 5483);
STAT1 (14994); STAT3 (9139); TAX1BP1 (5105); TBK1 (3013).
For IP of SQSTM1 MBL antibody (PM045) was used and as
control guinea pig IgG (Santa Cruz Biotechnology, sc-2711). To
inhibit IFNAR1 signaling, anti-IFNAR2/interferon-a/b receptor
chain 2 (Merck Millipore, MAB1155) was used. SQSTM1 antibodies used in Fig. S1G were from: BD (610832), Santa Cruz
Biotechnology (sc-28359), Abnova (H00008878-M03), Abcam
(ab31782) and Progen (GP62-C). All secondary antibodies were
from Invitrogen (Alexa Fluor conjugates; A32723, A32727,
A32732, A32731, A-11073, A-21435), Li-Cor Biotechnology
(NIR dye conjugates; 925–68070, 925–68071, 925–68074, 925–
32210, 925–32211, 925–32411, 925–68077) or Dako (HRP conjugates; P0448, P0447).
ROS detection
Cell were stained with 0.4 mM of the ROS-sensitive probe CMH2DCFDA (Invitrogen, C6827) for 30 min at 37 C and mean
ﬂuorescence was analyzed by a BD FACS Canto (BD Biosciences, San Jose, CA, USA). Experiments were performed in duplicates with 10,000 cells per condition.
Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated by using the RNeasy kit (Qiagen,
74106). Total RNA (1 mg) was used for cDNA synthesis with
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the High-Capacity RNA-to-cDNA Kit (Applied Biosystems,
4387406). Real-time PCR was performed using PerfeCTa qPCR
FastMix ROX (Quanta, QUNT95077–012) and TaqManÒ
Gene Expression Assays (Applied Biosystems). The cycling
conditions for the StepOne plus system (Applied Biosystems)
were 45 C for 2 min, 95 C for 30 sec, 40 cycles of 95 C for
1 sec, 60 C for 20 sec. The following probes were used:
CXCL10 (Hs01124251_g1), Cxcl10 (Mm00445235_m1),
CXCL11 (Hs04187682_g1), IFNB1 (Hs01077958_s1), TNF
(Hs01113624_g1), Tnf (Mm00443260_g1), GAPDH (Hs99999
905_m1), Gapdh (Mm99999915_g1), KEAP1 (Hs00202
227_m1), SQSTM1 (Hs00177654_m1), HMOX1 (Hs011102
50_m1), NQO1 (Hs00168547_m1) and SLC7A11 (Hs009219
38_m1). Relative mRNA levels were transformed into linear
form by the 2(-DDCt) method.76 Transcripts were normalized
to GAPDH.
Nanostring
Total RNA was extracted and mRNA transcripts were assessed
by digital transcript counting (nCounter GX Human Immunology kit assay, NanoString Technologies, Seattle, WA, USA).
Total RNA (100 ng) was assayed on nCounter Digital Analyzer
(NanoString) according to the manufacturer’s instructions.
Data were normalized by scaling with the geometric mean of
the built-in control gene probes for each sample.
Immunoblotting
For total protein extracts, 8 M urea lysis buffer was used (8 M
urea, 0.5% [v:v] Triton X-100 [Sigma-Aldrich, X100], DTT
[100 mM], CompleteÒ protease inhibitor [PI; Roche,
11873580001]), long with phosphatase inhibitor cocktail (PIC)
2 and 3 (Sigma, P5726 and P0044). Protein concentration was
determined by Bio-Rad protein assay (Bio-Rad 500–0006). Proteins (50 mg) were separated using NuPAGEÒ NovexÒ Bis-Tris
Gels (Invitrogen, NP0322, NP0321, WG1403, WG1402A),
transferred to nitrocellulose membranes using Invitrogen’s
iBlot system. Bound antibodies were imaged using appropriate
near-infrared (NIR) dye conjugates (Li-Cor) and an Odyssey
NIR scanner (Li-Cor Biosciences) or using HRP-linked secondary antibodies (Dako) and SuperSignal West Femto substrate
(Pierce, 34096) with a Li-Cor Odyssey Fc System. Image studio
3.1 was used for quantiﬁcation. For statistical assessment, mean
intensity values were used, while bar graphs of quantiﬁcations
show fold changes.
Soluble and insoluble fractions
Cells were lysed in a detergent buffer (NP-40 [1%; Calbiochem,
492018], Triton X-100 [0.25%; Sigma-Aldrich, X100], 0.05 M
Tris-HCl, 0.15 M NaCl, 0.001 M EDTA, PI, PIC2 and 3) and
lysates cleared by centrifugation (1000 g, 10 min). Supernatants
were centrifuged at 10,000 g for 20 min and the new supernatant collected (soluble fraction). The detergent-resistant pellet
was washed twice and ﬁnally resuspended in 8 M urea lysis
buffer (insoluble fraction).
Nuclear extraction
Cells were lysed in a hypotonic buffer containing 10 mM
HEPES, pH 7.4, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT,

0.1% NP-40, PI, and PIC2 and 3. Lysates were kept on ice, vortexed for 15 min and centrifuged at 3000 g for 10 min. The
nuclear pellet was washed once and ﬁnally resuspended in 8 M
urea lyis buffer. Cytoplasmic extracts were added to 20% 8 M
urea buffer.
Immunostaining
The cells were ﬁxed in 4% formaldehyde, permeabilized with
methanol, blocked with 3% goat-serum (Sigma-Aldrich,
G9023) and stained with primary and ﬂuorescently labeled secondary antibodies (Alexa Fluor conjugates, Invitrogen).
Nuclear DNA was stained using Draq5 (5 mM; Biostatus,
DR50200) or Hoechst 33342 (5 mg/ml; Life Technologies,
C10337). Imaging was done on an Axiovert200 microscope
with a 63 £ 1.2W objective and the confocal module LSM510
META (Carl Zeiss). Images were processed using the ZEN software (Zeiss) and mounted using Canvas 11 (Deneba).
ScanR automated image acquisition
The microscope-based imaging platform ScanR (Olympus, Hamburg, Germany) was used to image SQSTM1/p62-bodies. Images
were taken with a 20x objective, using the excitation ﬁlters
(wavelength [nm]/width [nm]): FITC (485/20), Alexa Fluor 647
(640/30) and Hoechst (650/13). For emission, a combination ﬁlter (440/521/607/700) was used for all ﬂuorophores (Chroma
Technology Corp, Bellows Falls, VT, USA). The images were
analysed by the ScanR Analysis software (Olympus).
Small interfering RNA
MDMs were transfected at d 5 and d 7 using Lipofectamine RNAiMAX (Invitrogen, 13778150) using 20 nM siRNA or nontargeting
oligo. The following smartpool siRNA oligonucleotides were
obtained from Dharmacon: nontargeting (D-001210–01),
SQSTM1 (J-010230–06), TAX1BP1 (L-016892–00), TNFAIP3 (L009919–00) and KEAP1 (LQ-012453–00).
ELISA
CXCL10 in supernatants and serum was quantiﬁed using an
ELISA Duo-Set (DY266 [human] or DY466 [murine], R&D,
Abingdon, UK) according to the manufacturer’s instruction.
IL36G in serum was quantiﬁed using a human IL-36G/IL-1F9
ELISA Kit (EHIL36G, Thermo Scientiﬁc).
IP and mass spectrometry (MS) analyses
For Santa Cruz Biotechnology, Dynabeads protein A (Life
Technologies, 10002D) were incubated with antibodies for 1 h
at room temperature and complexes were crosslinked with BS3
(Life Technologies, 21580) according to the manufacturer’s
protocol. Cells were lysed in a buffer containing 0.25% TX-100,
1% NP-40, 50 mM Tris-HCl, pH 8, 150 mM NaCl, 1 mM
EDTA, pH 8, PI, PIC 2 and 3. Lysates were adjusted for concentration and volume and immunoprecipitated at 4 C overnight.
Beads were washed 3 times with 400 mM KCl and eluted with
LDS sample buffer (Invitrogen, NP0007) at 80 C. For MS, eluates were run into NuPAGEÒ Gels and stained with SimplyBlue
SafeStain (Life Technologies, LC6060). Gel pieces were subjected to in-gel reduction, alkylation, and tryptic digestion
using 6 ng/ml trypsin (Promega, V511A).77 OMIX C18 tips
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(Varian, Inc., Palo Alto, CA, USA) were used for sample clean
up and concentration. Peptide mixtures containing 0.1% formic
acid were loaded onto a Thermo Fisher Scientiﬁc EASY
nLC1000 system and EASY-Spray column (C18, 2 mm, 100 A,
50 mm, 15 cm). Peptides were fractionated using a 2–100% acetonitrile gradient in 0.1% formic acid over 50 min at a ﬂow rate
of 250 nl/min. The separated peptides were analyzed using a
Thermo Scientiﬁc Q-Exactive mass spectrometer. Data were
collected in data-dependent mode using a Top10 method. The
raw data were processed using the Proteome Discoverer 1.4
software. The fragmentation spectra were searched against the
Swissprot SwissProt_2011_12 database using an in-house
Mascot server (Matrix Sciences, UK). Peptide mass tolerances
used in the search were 10 ppm, and fragment mass tolerance
was 0.02 Da. Peptide ions were ﬁltered using a false discovery
rate set to 5% for peptide identiﬁcations.

Animals
Protocols were approved by the Washington University Animal
Studies Committee. Mice used in this study were in the C57BL/
6 background and housed in a speciﬁc pathogen-free barrier
facility. sqstm1¡/¡ mice were as described previously.54,78

Patients
Thirty-ﬁve clinically stable hypertensive heart transplant recipients were studied 1–12 y after transplantation and randomized
in a double-blind fashion to receive either 3.4 g of omega-3
fatty acids daily or placebo (corn oil) for one y in the OmaCorstudy.49,50 Plasma was sampled for cytokine analyses after overnight fasting at baseline and after 12 mo. The study was
approved by the Regional Ethics Committee and all patients
gave written informed consent for participation.

Statistical analysis
Statistical analyses were performed in Prism 6 (Graph pad).
Values are expressed as mean § standard error of the mean
(SEM) if not otherwise stated. Statistical analyses were performed on mRNA fold changes compared to vehicle or on
intensities obtained by densitometry of immunoblots, confocal
images or FACS analysis. Data from primary cells was analyzed
by nonparametric tests where possible; data from cell lines was
logtransformed and analyzed by parametric tests as indicated.
Coefﬁcients of correlation (r) were calculated using the Spearman’s rank test. P-value < 0.05 was considered statistically signiﬁcant and is labeled with , and p < 0.01 is labeled with ,
p < 0.001 labeled with .

Ethics statement
The Regional Committees for Medical and Health Research
Ethics at the Norwegian University of Science and Technology
(NTNU) approved the use of PBMCs from healthy adult blood
donors after informed consent (identiﬁcation number 2009/
2245–2). All donors provided written informed consent.

1675

Abbreviations
AA
ACTB
ALIS
ATG8
BafA1
CHUK/IKKa
COX4I1
CXCL10
DHA
DUB
FFAR4/GPR120
GAPDH
HMOX1
IB
IFN
IFNAR1
IKBKB/IKKb
IP
IRF
KEAP1
LIR
LMNA
LPS
MAP1LC3B
MAPK1/ERK2
MAPK3/ERK1
MDM
n-3 PUFA
NAC
NFE2L2/NRF2
NFKB
NFKB2/p105
NQO1
OA
PCNA
PIC
RELA/p65
p(I:C)
ROS
RPE
SLC7A11/xCT
SQSTM1/p62
STAT1
TAX1BP1
TBK1
TLR4
TNFAIP3/A20
TNF
Ub
UBA

arachidonic acid
actin b
aggresome-like induced structures
autophagy-related 8
baﬁlomycin A1
conserved helix-loop-helix ubiquitous kinase
cytochrome c oxidase subunit 4I1
C-X-C motif chemokine ligand 10
docosahexaenoic acid
deubiquitinating enzyme
free fatty acid receptor 4
glyceraldehyde-3-phosphate dehydrogenase
heme oxygenase 1
immunoblot
interferon
interferon a and b receptor subunit 1
inhibitor of nuclear factor kappa B kinase
subunit b
immunoprecipitation
interferon regulatory factor
kelch like ECH associated protein 1
light chain 3 (LC3)-interacting region
lamin A/C
lipopolysaccharide
microtubule associated protein 1 light chain
3b
mitogen-activated protein kinase 1
mitogen-activated protein kinase 3
monocyte-derived macrophages
omega-3 polyunsaturated fatty acid
N-acetylcysteine
nuclear factor, erythroid 2 like 2
nuclear factor kappa B
nuclear factor kappa B subunit 2
NAD(P)H quinone dehydrogenase 1
oleic acid
proliferating cell nuclear antigen
phosphatase inhibitor cocktail
RELA proto-oncogene, NF-kB subunit
poly I:C
reactive oxygen species
retinal pigment epithelium
solute carrier family 7 member 11
sequestosome 1
signal transducer and activator of transcription 1
Tax1 binding protein 1
TANK binding kinase 1
toll like receptor 4
TNF a induced protein 3
tumor necrosis factor
ubiquitin
ubiquitin-associated domain
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